A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy. [electronic resource]
Producer: 20151008Description: 517-30 p. digitalISSN:- 1096-9896
- Animals
- Antineoplastic Agents -- therapeutic use
- Cell Line, Tumor
- Cell Proliferation
- Disease Progression
- Drug Design
- Gene Expression Regulation, Neoplastic
- Glycolysis
- Humans
- Lactic Acid -- metabolism
- Male
- Mice, Transgenic
- Molecular Targeted Therapy
- Monocarboxylic Acid Transporters -- antagonists & inhibitors
- Neoplasm Staging
- Phenotype
- Prostatic Neoplasms -- drug therapy
- RNA Interference
- Time Factors
- Transfection
- Tumor Burden
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.